A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer.
about
Bioinformatics analysis of the proteins interacting with LASP-1 and their association with HBV-related hepatocellular carcinoma.Effect of Akt activation and experimental pharmacological inhibition on responses to neoadjuvant chemoradiotherapy in rectal cancer.Developing a genetic signature to predict drug response in ovarian cancer.
P2860
A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A Predictive Genetic Signature ...... tage II and III Rectal Cancer.
@en
A Predictive Genetic Signature ...... tage II and III Rectal Cancer.
@nl
type
label
A Predictive Genetic Signature ...... tage II and III Rectal Cancer.
@en
A Predictive Genetic Signature ...... tage II and III Rectal Cancer.
@nl
prefLabel
A Predictive Genetic Signature ...... tage II and III Rectal Cancer.
@en
A Predictive Genetic Signature ...... tage II and III Rectal Cancer.
@nl
P2093
P2860
P356
P1476
A Predictive Genetic Signature ...... tage II and III Rectal Cancer.
@en
P2093
Andrea McCulla
Conor Delaney
Harry Reynolds
Huankai Hu
Jason Chan
Joseph E Willis
Michael T Kinsella
Patrick G Johnston
Steve Deharo
Timothy J Kinsella
P2860
P356
10.3389/FONC.2013.00288
P577
2013-11-25T00:00:00Z